Expression of activation-induced cytidine deaminase in human B-cell non-hodgkin lymphomas

Blood

Volumn 101, Issue 9, 2003, Pages 3574-3580

  Greeve, Jobst ^a   Philipsen, Antje ^b   Krause, Kristina ^b   Klapper, Wolfram ^b   Heidorn, Klaus ^b   Castle, Brian E ^b   Janda, Joe ^b   Marcu, Kenneth B ^b   Parwaresch, Reza ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; CYTIDINE DEAMINASE; HERMES ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; MESSENGER RNA; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CD38 PROTEIN, HUMAN; CD40 LIGAND; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 4; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PRDM1 PROTEIN, HUMAN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EXON; FOLLICULAR LYMPHOMA; GENE; GENE EXPRESSION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOMA; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PLASMA CELL; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA SPLICING; SAMPLE; SOMATIC HYPERMUTATION; STEM CELL; B CELL LEUKEMIA; B CELL LYMPHOMA; BIOSYNTHESIS; CANCER STEM CELL; COMPARATIVE STUDY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENETIC RECOMBINATION; GENETICS; IMMUNOGLOBULIN GENE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD38; B-LYMPHOCYTES; CD40 LIGAND; CYTIDINE DEAMINASE; ENZYME INDUCTION; EXONS; GENES, IMMUNOGLOBULIN; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INTERLEUKIN-4; LEUKEMIA, B-CELL, CHRONIC; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; RECOMBINATION, GENETIC; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSCRIPTION FACTORS; TUMOR STEM CELLS;

EID: 0037866404     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-08-2424     Document Type: Article

References (36)

1. Gaidano G, Dalla-Favera R. Pathobiology of non-Hodgkin's lymphoma. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: Basic Principles and Practice. New York, NY: Churchill Livingstone; 2000:1213-1229.
2. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
3. Ramsden DA, van Gent DC, Gellert M. Specificity in V(D)J recombination: new lessons from biochemistry and genetics. Curr Opin Immunol. 1997;9:114-120.
4. Ramsden DA, Paull TT, Gellert M. Cell-free V(D)J recombination. Nature. 1997;388:488-491.
5. Jacobs H, Bross L. Towards an understanding of somatic hypermutation. Curr Opin Immunol. 2001;13:208-218.
6. Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol. 2002;20:165-196.
7. Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM Syndrome (HIGM2). Cell. 2002;102:565-575.
8. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102:553-563.
9. Arakawa H, Hauschild J, Buerstedde J-M. Requirement of the activation-induced deaminase (AID) gene for immunoglobuline gene conversion. Science. 2002;295:1301-1306.
10. Fugmann SD, Schatz DG. One AID to unite them all. Science. 2002;295:1244-1245.
11. Muramatsu M, Sankaranand VS, Anant S, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem. 1999;274:18470-18476.
12. Teng BB, Burand CF, Davidson NO. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 1993;260:1816-1819.
13. Espinosa R, Funahashi T, Hadjiagapiou C, Lebeau MM, Davidson NO. Assignment of the gene encoding the human apolipoprotein B mRNA editing enzmye (APOBEC-1) to chromosome 12p13.1. Genomics. 1994;24:414-415.
14. Muro T, Muramatsu M, Tanikawi M, Kinoshita K, Honjo T. Isolation, tissue distribution and chromosomal localization of the human activation-induced cytidine deaminase gene. Genomics. 2000;15:85-88.
15. Navaratnam N, Morrison JR, Battacharya S, et al. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem. 1993;268:20709-20712.
16. Lellek H, Kirsten R, Diehl I, Apostel F, Buck F, Greeve J. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J Biol Chem. 2000;27;19848-19856.
17. Metha A, Kinter MT, Sherman NE, Driscoll DM. Molecular cloning of APOBEC-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol. 2000;20:1846-1854.
18. Lellek H, Welker S, Diehl I, Kirsten R, Greeve J. Reconstitution of mRNA editing in yeast using a Gal4-ApoB-Gal80 fusion transcript as the selectable marker. J Biol Chem. 2002;277:23638-23644.
19. Okazaki I, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature. 2002;416:340-345.
20. Yoshikawa K, Okazaki I, Eto T, et al. AID enzymeinduced hypermutation in an actively transcribed gene in fibroblasts. Science. 2002;296:2033-2036.
21. Petersen-Mahrt SK, Harris RS, Neuberger MS. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 2002;418:99-103.
22. Di Noia J, Neuberger M. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature. 2002;419:43-48.
23. Yamanaka S, Balestra ME, Ferrell LD, et al. Apolipoprotein B mRNA editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A. 1995;92:8483-8487.
24. Greeve J, Altkemper I, Dieterich JD, Greten H, Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apo B-containing plasma lipoproteins. J Lipid Res. 1993;34:1367-1384.
25. Greeve J, Lellek H, Apostel F, et al. Absence of APOBEC-1 mediated mRNA editing in human carcinomas. Oncogene. 1999;18:6357-6366.
26. Greeve J, Axelos D, Welker S, Schipper M, Greten H. Distinct promotors induce APOBEC-1 expression in rat liver and intestine. Arterioscler Thromb Vasc Biol. 1998;18:1079-1092.
27. Küppers R, Zhao M, Raiewski K, Hansmann ML. Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction. Am J Pathol. 1993;143:230-239.
28. Kreipe H, Heidebrec hat HJ, Hansen S, et al. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. Am J Pathol. 1993;142:3-9.
29. Huang JZ, Sanger WG, Greiner TC, et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood. 2002;99:2285-2290.
30. Rajewski K. Clonal selection and learning in the antibody system. Nature. 1996;381:751-758.
31. Longacre A, Strorb U. A novel cytidine deaminase affects antibody diversity. Cell. 2000;102:541-544.
32. Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A. 1995;92:12520-12524.
33. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 1998;280:1750-1752.
34. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutation in normal B cells: eidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A. 1998;95:11816-11821.
35. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001;412:341-346.
36. Shaffer AL, Lin K, Kuo TC, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 2002;17:51-62.